Sugar coated tablets are water-soluble that makes it easier to dissolve quickly in the stomach. Sugar coating is used to protect the drug inside the tablet and act as a barrier to external contaminants. It also prevents light or moisture from entering the tablet, which causes the drug to break down quickly. Such advantages of sugar coated tablets are expected to boost the growth of the global sugar coated tablets market. Moreover, the manufacturing of sugar coated tablets requires inexpensive and readily available raw materials and simple equipment. The use of raw materials in sugar coated tablets faces few regulatory issues and the process is easily documented and controlled to meet modern GMP standards. Such a scenario is also expected to propel the growth of the market over the forecast period.
Increasing preference for tablets instead of surgical procedures is also expected to boost growth of the global sugar coated tablets market. Increasing prevalence of migraines and rheumatoid arthritis is expected to boost the growth of the market. Ibuprofen 400 mg developed by Mylan Products Limited is a sugar coated tablet used for the treatment of migraines and rheumatoid arthritis. According to the Centers for Disease Control and Prevention March 2017 Vital Signs, 54.4 million U.S. adults suffer from arthritis - equating to about 25% of the population. By 2040, an estimated 78 million (26%) U.S. adults ages 18 years or older are projected to have doctor-diagnosed arthritis.
Moreover, the high incidence of irritable bowel syndrome, spastic constipation, mucous colitis, and spastic colitis is also expected to boost growth of the market. Colofac tablets are used in the treatment of these diseases. For instance, in a meta-analysis of 10 studies published by National Center for Biotechnology Information (NCBI), the pooled prevalence of irritable bowel syndrome in the U.S. was estimated to be 11.8% and the disease is reported more frequently in women than in men and in individuals aged 30 to 49 years compared with those 50 years and older.
However, sugar coated tablets are large in size, which has prompted drug manufacturers to opt for film coatings in the recent past, which is expected to hinder growth of the market. Moreover, sugar coated tablets are prone to cracking as the tablet cores expands either during or after coating. Sugar coatings also fail to dry properly. It is also not suitable to grind up reject sugar-coated tablets for recompaction, owing to the amount of material applied as a coating in the sugar-coating process.
Key Takeaways
• Availability of inexpensive raw materials and simple equipment for the production of sugar coated tablets to augment growth of the market
• Increasing adoption of film coating is expected to hinder growth of the market
• Key players operating in the global sugar coated tablets market include Pfizer, Inc., Novartis, Yangtze River Pharmaceutical Group, Bayer, Xinhua Pharmaceutical, Harbin Pharmaceutical, Eisai, NCPC, GSK, and Gebro
World economic growth, the Sugar Coated Tablets industry has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years, Sugar Coated Tablets market size to maintain the average annual growth rate of 0.0165836263826 from 1400.0 million $ in 2014 to 1520.0 million $ in 2020, Stratagem Market Insights analysts believe that in the next few years, Sugar Coated Tablets market size will be further expanded, we expect that by 2026, The market size of the Sugar Coated Tablets will reach 1630.0 million $.
This Report covers the manufacturers' data, including: shipment, price, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the competitors better. This report also covers all the regions and countries of the World, which shows a regional development status, including market size, volume and value, as well as price data.
Besides, the report also covers segment data, including: type segment, industry segment, channel segment etc. cover different segment market size, both volume and value. Also cover different industries clients information, which is very important for the manufacturers. If you need more information,
Section 1: Definition
Section (2 3): Manufacturer Detail
Pfizer
Novartis
Yangze River Pharmacelltcal
Bayer
XINHUA PHARMACEUTICAL
Harbin Pharmaceutical
Eisai
NCPC
GSK
Gebro
Section 4: Region Segmentation
North America Country (United States, Canada)
South America
Asia Country (China, Japan, India, Korea)
Europe Country (Germany, UK, France, Italy)
Other Country (Middle East, Africa, GCC)
Section (5 6 7): Segmentation
Product Type Segmentation:
-- Colored Sugar Coated Tablets
-- Colorless Sugar Coated Tablets
Industry Segmentation:
-- Cardiovascular Diseases
-- Gastrointestinal Disease
-- Neurological Diseases
-- Immune Disease
Channel (Direct Sales, Distributor) Segmentation
Section 8: Trend (2020-2026)
Section 9: Product Type Detail
Section 10: Downstream Consumer
Section 11: Cost Structure
Section 12: Conclusion
Request Discount 
Inquire Before Buy
